TRON: A trial to examine the effectiveness of the study drug (Everolimus) in the treatment of cognitive problems experienced by patients with tuberous sclerosis

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-004854-25

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to determine how effective Everolimus is compared to a placebo for recall memory (remembering events or information) and executive function (the ability to organise thoughts and activities, prioritise tasks, manage time and make decisions) in people with tuberous sclerosis over a 6 month period.


Critère d'inclusion

  • Tuberous Sclerosis Complex (TSC)

Liens